Detalhe da pesquisa
1.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Lancet;
2024 May 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38795719
2.
Coronary bypass surgery guided by computed tomography in a low-risk population.
Eur Heart J;
45(20): 1804-1815, 2024 May 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38583086
3.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
N Engl J Med;
385(18): 1643-1655, 2021 10 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34449185
4.
Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design.
BMC Cardiovasc Disord;
24(1): 62, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38245724
5.
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
Eur Heart J;
44(41): 4340-4356, 2023 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37208199
6.
Merging virtual and physical experiences: extended realities in cardiovascular medicine.
Eur Heart J;
44(35): 3311-3322, 2023 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37350487
7.
Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
Circulation;
146(17): 1268-1280, 2022 10 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35862109
8.
Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN).
Circ J;
87(6): 857-865, 2023 05 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36908118
9.
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
Eur Heart J;
43(13): 1334-1344, 2022 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34405875
10.
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Eur Heart J;
43(13): 1307-1316, 2022 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34617993
11.
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.
Circulation;
144(2): 96-109, 2021 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34011163
12.
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
Circulation;
144(15): 1196-1211, 2021 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34455849
13.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation;
143(5): 479-500, 2021 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33523728
14.
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
Am Heart J;
246: 32-43, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34990582
15.
Usability of Fantom Encore® scaffold in non-complex bifurcations-Analysis in bench models.
Catheter Cardiovasc Interv;
99(2): 424-432, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33565719
16.
Plaque burden estimated from optical coherence tomography with deep learning: In vivo validation using co-registered intravascular ultrasound.
Catheter Cardiovasc Interv;
2022 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36519717
17.
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Catheter Cardiovasc Interv;
100(1): 72-82, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35500171
18.
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
Eur Heart J;
43(1): 56-67, 2021 12 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34405232
19.
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Lancet;
396(10260): 1399-1412, 2020 10 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33038944
20.
A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study.
Am Heart J;
239: 19-26, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33992606